drugset / Trial / NCT00031395

Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children

NCT00031395

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of clonidine alone or in combination with methylphenidate for children 7-12 years of age with attention-deficit, hyperactivity disorder.

Timeline

Start
1999-09
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clonidine Other / unclassified
Comparator Methylphenidate Small molecule